66 related articles for article (PubMed ID: 26088937)
1. Protein deregulation associated with breast cancer metastasis.
Chan KK; Matchett KB; McEnhill PM; Dakir el H; McMullin MF; El-Tanani Y; Patterson L; Faheem A; Rudland PS; McCarron PA; El-Tanani M
Cytokine Growth Factor Rev; 2015 Aug; 26(4):415-23. PubMed ID: 26088937
[TBL] [Abstract][Full Text] [Related]
2. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis.
Urquidi V; Sloan D; Kawai K; Agarwal D; Woodman AC; Tarin D; Goodison S
Clin Cancer Res; 2002 Jan; 8(1):61-74. PubMed ID: 11801541
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1.
Hedley BD; Welch DR; Allan AL; Al-Katib W; Dales DW; Postenka CO; Casey G; Macdonald IC; Chambers AF
Int J Cancer; 2008 Aug; 123(3):526-34. PubMed ID: 18470911
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms involved in breast cancer liver metastasis.
Ma R; Feng Y; Lin S; Chen J; Lin H; Liang X; Zheng H; Cai X
J Transl Med; 2015 Feb; 13():64. PubMed ID: 25885919
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.
Labelle M; Schnittler HJ; Aust DE; Friedrich K; Baretton G; Vestweber D; Breier G
Cancer Res; 2008 Mar; 68(5):1388-97. PubMed ID: 18316602
[TBL] [Abstract][Full Text] [Related]
7. The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis.
Imamura T; Hikita A; Inoue Y
Breast Cancer; 2012 Apr; 19(2):118-24. PubMed ID: 22139728
[TBL] [Abstract][Full Text] [Related]
8. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
[TBL] [Abstract][Full Text] [Related]
9. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis.
Lou Y; Preobrazhenska O; auf dem Keller U; Sutcliffe M; Barclay L; McDonald PC; Roskelley C; Overall CM; Dedhar S
Dev Dyn; 2008 Oct; 237(10):2755-68. PubMed ID: 18773493
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
[TBL] [Abstract][Full Text] [Related]
13. Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.
Sin S; Bonin F; Petit V; Meseure D; Lallemand F; Bièche I; Bellahcène A; Castronovo V; de Wever O; Gespach C; Lidereau R; Driouch K
J Natl Cancer Inst; 2011 Sep; 103(17):1323-37. PubMed ID: 21832234
[TBL] [Abstract][Full Text] [Related]
14. VDR status arbitrates the prometastatic effects of tumor-associated macrophages.
Zhang Y; Guo Q; Zhang Z; Bai N; Liu Z; Xiong M; Wei Y; Xiang R; Tan X
Mol Cancer Res; 2014 Aug; 12(8):1181-91. PubMed ID: 24821711
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of TGF beta 1 and TGF beta 3 in human breast carcinoma.
Ghellal A; Li C; Hayes M; Byrne G; Bundred N; Kumar S
Anticancer Res; 2000; 20(6B):4413-8. PubMed ID: 11205281
[TBL] [Abstract][Full Text] [Related]
16. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
[TBL] [Abstract][Full Text] [Related]
17. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.
Mern DS; Hoppe-Seyler K; Hoppe-Seyler F; Hasskarl J; Burwinkel B
Breast Cancer Res Treat; 2010 Dec; 124(3):623-33. PubMed ID: 20191379
[TBL] [Abstract][Full Text] [Related]
18. TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells.
Sengupta S; Jana S; Bhattacharyya A
Cell Signal; 2014 Feb; 26(2):240-52. PubMed ID: 24269534
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer-derived factors facilitate osteolytic bone metastasis.
Rose AA; Siegel PM
Bull Cancer; 2006 Sep; 93(9):931-43. PubMed ID: 16980236
[TBL] [Abstract][Full Text] [Related]
20. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
